Tezacaftor

N/A

Report date: 2024/05/17 10:16:21
NME

Base Information

Drug NameTezacaftor
Drug Alias Name特扎卡托Tezacaftorum替扎卡托VX-6618RW88Y506K (UNII code) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulants
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[20] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals IncorporatedCystic Fibrosis Foundation Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesCystic Fibrosis Foundation TherapeuticsVertex Pharmaceuticals Incorporated
Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A